Lexby WheresMyMEPGet Pro free

Angelini Pharma has 16 disclosed EU lobbying meetings from 2024-11-11 to 2026-04-29: 0 with the European Commission and 16 with Members of the European Parliament. Source: EU Transparency Register no. 544580951592-90, Commission disclosures and MEP declarations. Methodology

Angelini Pharma

EU lobbying footprint — who they meet, and on what.

Register no.
544580951592-90 ↗
Disclosed meetings
16 (0 Commission · 16 MEP)
Period
2024-11-11 → 2026-04-29

Declared fields of interest: Business and industry · Public health · Research and innovation

Lobbying profile

as declared 2025-10-15
Category
Companies & groups
Legal status
S.p.A.
Declared lobbying cost
€50,000
Lobbying FTEs
0.25
Members
1
LobbyFacts / Transparency Register source ↗

At a glance

Most-met policy areas
  • Health policy2
  • BIOTECH ACT1
  • Incontro conoscitivo1
  • Introductory Meeting1
  • Public Heath1

Disclosed meetings

Newest first. EC = European Commission, EP = Member of the European Parliament.

Frequently asked

How many EU lobbying meetings has Angelini Pharma disclosed?

Angelini Pharma (EU Transparency Register no. 544580951592-90) appears in 16 disclosed meetings with EU officials and MEPs between 2024-11-11 and 2026-04-29: 0 with the European Commission and 16 with Members of the European Parliament.

What does Angelini Pharma lobby on?

Angelini Pharma's disclosed EU meetings most often concern Health policy, BIOTECH ACT, Incontro conoscitivo, Introductory Meeting. Every meeting and its topic is listed with its official source on this page.

Who does Angelini Pharma meet in Brussels?

Across its disclosed meetings, Angelini Pharma has met MEPs including SOKOL Tomislav, KULJA András Tivadar, DE LA PISA CARRIÓN Margarita. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See how this affects your company →Ask Lex about Angelini Pharma →